MARKET

RDY

RDY

Dr Reddys Labs
NYSE
14.90
+0.07
+0.47%
Pre Market: 14.74 -0.16 -1.07% 09:13 01/21 EST
OPEN
14.90
PREV CLOSE
14.83
HIGH
14.94
LOW
14.81
VOLUME
265
TURNOVER
0
52 WEEK HIGH
16.89
52 WEEK LOW
13.35
MARKET CAP
12.41B
P/E (TTM)
19.57
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDY last week (0113-0117)?
Weekly Report · 2d ago
Dr Reddy’s Laboratories (RDY) Gets a Buy from Bank of America Securities
TipRanks · 5d ago
Weekly Report: what happened at RDY last week (0106-0110)?
Weekly Report · 01/13 09:05
Dr. Reddy’s Faces GST Tax Demand, Evaluates Appeal
TipRanks · 01/10 11:58
Dr. Reddy’s to Announce Q3FY25 Financial Results on January 23, 2025
TipRanks · 01/08 12:28
Dr. Reddy’s Sells Non-Strategic Louisiana Subsidiary
TipRanks · 01/08 11:48
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
NASDAQ · 01/07 14:50
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Benzinga · 01/06 15:40
More
About RDY
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Webull offers Dr Reddy's Laboratories Ltd (ADR) stock information, including NYSE: RDY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDY stock methods without spending real money on the virtual paper trading platform.